Loading...
XJPX
9987
Market cap2.64bUSD
Dec 05, Last price  
5,872.00JPY
1D
-1.66%
1Q
-2.52%
Jan 2017
53.72%
Name

Suzuken Co Ltd

Chart & Performance

D1W1MN
XJPX:9987 chart
P/E
11.90
P/S
0.17
EPS
493.48
Div Yield, %
1.53%
Shrs. gr., 5y
-3.55%
Rev. gr., 5y
1.63%
Revenues
2.40t
+0.56%
1,388,694,000,0001,454,842,000,0001,586,583,000,0001,641,386,000,0001,735,481,000,0001,751,961,000,0001,859,934,000,0001,894,611,000,0001,988,137,000,0001,969,683,000,0002,228,204,000,0002,127,076,000,0002,124,016,000,0002,132,345,000,0002,213,532,000,0002,128,478,000,0002,232,774,000,0002,314,828,000,0002,386,493,000,0002,399,952,000,000
Net income
34.50b
+18.89%
17,183,000,00017,702,000,00021,327,000,0007,072,000,00013,969,000,0009,627,000,0008,050,000,00014,350,000,00021,447,000,00018,920,000,00028,960,000,00021,308,000,00018,820,000,00030,204,000,00028,213,000,0007,895,000,00014,393,000,00020,345,000,00029,016,000,00034,496,000,000
CFO
-65.08b
L
19,636,000,00068,117,000,000-16,118,000,000-4,583,000,00031,913,000,00028,336,000,00065,542,000,00054,006,000,000-41,054,000,00047,209,000,00020,457,000,00027,013,000,00098,066,000,00041,751,000,000-25,817,000,00015,602,000,0009,520,000,00037,270,000,00087,216,000,000-65,079,000,000
Dividend
Mar 30, 202650 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.
URL
https://www.suzuken.co.jp/
IPO date
Aug 01, 1994
Employees
13,429
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT